TY - JOUR
T1 - Factors influencing quality of life in Indonesian children with osteogenesis imperfecta
AU - Satriono, Kwari J.
AU - Amalia, Gassani
AU - Andarie, Attika Adrianti
AU - Wiguna, Tjhin
AU - Pardede, Sudung Oloan
AU - Soesanti, Frida
AU - Pulungan, Aman B.
N1 - Publisher Copyright:
© Copyright by Polish Society of Pediatric Endocrinology and Diabetes 2024.
PY - 2024
Y1 - 2024
N2 - Introduction: Osteogenesis imperfecta (OI), a rare condition, profoundly impacts a child’s life. It leads to mobility issues, deformities from frequent fractures, psychosocial and mental-emotional issues, and, indirectly, financial problems that can compromise quality of life (QoL). Clinical severity, classified as mild-moderate or severe, is linked to the overall disease burden. Aim of the study: The objective of the study was to determine how QoL in OI patients is associated with physical, mental-emotional, psychosocial, and socioeconomic problems. Material and methods: We conducted a cross-sectional study using questionnaires (PEDS QL 4.0 for QoL, SDQ for mental-emotional problems, PSC-17 for psychosocial problems, and World Bank for assessing financial problems) on OI patients aged 4–18 years in Jakarta, Indonesia. Both parents and patients filled out the questionnaires. Results: Fifty subjects participated in this study. Parent-reported QoL was associated with the severity of disease (PR = 3.429, p = 0.029) and there was an association of patient-reported QoL with compliance to bisphosphonate therapy (PR = 3.167, p = 0.043) and short stature (PR = 3.36, p = 0.014). Both parent- and patient-reported QoL were strongly associated with the physical and psychosocial problems domain of the PEDS QL 4.0 (p < 0.001). Conclusions: Evaluating OI patients should prioritise QoL because more severe OI is associated with more severe QoL problems. No evidence of association was found between OI disease severity and family income.
AB - Introduction: Osteogenesis imperfecta (OI), a rare condition, profoundly impacts a child’s life. It leads to mobility issues, deformities from frequent fractures, psychosocial and mental-emotional issues, and, indirectly, financial problems that can compromise quality of life (QoL). Clinical severity, classified as mild-moderate or severe, is linked to the overall disease burden. Aim of the study: The objective of the study was to determine how QoL in OI patients is associated with physical, mental-emotional, psychosocial, and socioeconomic problems. Material and methods: We conducted a cross-sectional study using questionnaires (PEDS QL 4.0 for QoL, SDQ for mental-emotional problems, PSC-17 for psychosocial problems, and World Bank for assessing financial problems) on OI patients aged 4–18 years in Jakarta, Indonesia. Both parents and patients filled out the questionnaires. Results: Fifty subjects participated in this study. Parent-reported QoL was associated with the severity of disease (PR = 3.429, p = 0.029) and there was an association of patient-reported QoL with compliance to bisphosphonate therapy (PR = 3.167, p = 0.043) and short stature (PR = 3.36, p = 0.014). Both parent- and patient-reported QoL were strongly associated with the physical and psychosocial problems domain of the PEDS QL 4.0 (p < 0.001). Conclusions: Evaluating OI patients should prioritise QoL because more severe OI is associated with more severe QoL problems. No evidence of association was found between OI disease severity and family income.
KW - child
KW - osteogenesis imperfecta
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85216454610&partnerID=8YFLogxK
U2 - 10.5114/pedm.2024.142588
DO - 10.5114/pedm.2024.142588
M3 - Article
C2 - 39963054
AN - SCOPUS:85216454610
SN - 2081-237X
VL - 30
SP - 174
EP - 182
JO - Pediatric Endocrinology, Diabetes and Metabolism
JF - Pediatric Endocrinology, Diabetes and Metabolism
IS - 4
ER -